Loading...
|
ab14873 |
NIH 3T3 (Mouse embryonic fibroblast cell line) Cytoplasmic lysate (ab14873) |
|
ab29546 |
HeLa (Human epithelial carcinoma cell line) Cytoplasmic Lysate (ab29546) |
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Signal Transduction >> Cytoskeleton / ECM >> Cytoskeleton >> Microfilaments >> Actin etc >> Actin Crosslinking
Anti-Filamin A antibody [EP2405Y] - Carboxyterminal end
See all Filamin A products (10) ...
Rabbit monoclonal [EP2405Y] to Filamin A - Carboxyterminal end
WB, IHC-P, ICC, Flow Cytmore details
Reacts with
Mouse, Rat, Human
A synthetic peptide corresponding to residues near the C terminal of human Filamin A.
COS-1, HeLa, 3T3 and C6 cell lysate and human uterus tissue and Hela cells.
Liquid
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Preservative: 0.01% Sodium Azide
Constituents: 40% Glycerol, 0.05% BSA, Tissue culture supernatant, 0.15M Sodium chloride, 50mM Tris glycine, pH 7.4
Tissue culture supernatant
Monoclonal
EP2405Y
IgG
Signal Transduction >> Cytoskeleton / ECM >> Cytoskeleton >> Microfilaments >> Actin etc >> Actin Crosslinking
Flow Cytometry-Filamin A antibody [EP2405Y] - Carboxyterminal end(ab76289)
(enlarge)
Western blot - Filamin A antibody [EP2405Y] - Carboxyterminal end (ab76289)
(enlarge)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Filamin A antibody [EP2405Y] - Carboxyterminal end (ab76289)
(enlarge)
Our Abpromise guarantee covers the use of ab76289 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: 1/250,000 - 1/500,000.Detects a band of approximately 281 kDa (predicted molecular weight: 281 kDa).
IHC-P: 1/100 - 1/250.Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
ICC: 1/100 - 1/250.
Flow Cyt: 1/100
Is unsuitable for or IP.
Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNA may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking.
Ubiquitous.
Defects in FLNA are the cause of periventricular nodular heterotopia type 1 (PVNH1) [MIM:300049]; also called nodular heterotopia, bilateral periventricular (NHBP or BPNH). PVNH is a developmental disorder characterized by the presence of periventricular nodules of cerebral gray matter, resulting from a failure of neurons to migrate normally from the lateral ventricular proliferative zone, where they are formed, to the cerebral cortex. PVNH1 is an X-linked dominant form. Heterozygous females have normal intelligence but suffer from seizures and various manifestations outside the central nervous system, especially related to the vascular system. Hemizygous affected males die in the prenatal or perinatal period.
Defects in FLNA are the cause of periventricular nodular heterotopia type 4 (PVNH4) [MIM:300537]; also known as periventricular heterotopia Ehlers-Danlos variant. PVNH4 is characterized by nodular brain heterotopia, joint hypermobility and development of aortic dilation in early adulthood.
Defects in FLNA are the cause of otopalatodigital syndrome type 1 (OPD1) [MIM:311300]. OPD1 is an X-linked dominant multiple congenital anomalies disease mainly characterized by a generalized skeletal dysplasia, mild mental retardation, hearing loss, cleft palate, and typical facial anomalies. OPD1 belongs to a group of X-linked skeletal dysplasias known as oto-palato-digital syndrome spectrum disorders that also include OPD2, Melnick-Needles syndrome (MNS), and frontometaphyseal dysplasia (FMD). Remodeling of the cytoskeleton is central to the modulation of cell shape and migration. FLNA is a widely expressed protein that regulates re-organization of the actin cytoskeleton by interacting with integrins, transmembrane receptor complexes and second messengers. Males with OPD1 have cleft palate, malformations of the ossicles causing deafness and milder bone and limb defects than those associated with OPD2. Obligate female carriers of mutations causing both OPD1 and OPD2 have variable (often milder) expression of a similar phenotypic spectrum.
Defects in FLNA are the cause of otopalatodigital syndrome type 2 (OPD2) [MIM:304120]; also known as cranioorodigital syndrome. OPD2 is a congenital bone disorder that is characterized by abnormally modeled, bowed bones, small or absent first digits and, more variably, cleft palate, posterior fossa brain anomalies, omphalocele and cardiac defects.
Defects in FLNA are the cause of frontometaphyseal dysplasia (FMD) [MIM:305620]. FMD is a congenital bone disease characterized by supraorbital hyperostosis, deafness and digital anomalies.
Defects in FLNA are the cause of Melnick-Needles syndrome (MNS) [MIM:309350]. MNS is a severe congenital bone disorder characterized by typical facies (exophthalmos, full cheeks, micrognathia and malalignment of teeth), flaring of the metaphyses of long bones, s-like curvature of bones of legs, irregular constrictions in the ribs, and sclerosis of base of skull.
Defects in FLNA are the cause of X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX) [MIM:300048]. CIIPX is characterized by a severe abnormality of gastrointestinal motility due to primary qualitative defects of enteric ganglia and nerve fibers. Affected individuals manifest recurrent signs of intestinal obstruction in the absence of any mechanical lesion.
Defects in FLNA are the cause of FG syndrome type 2 (FGS2) [MIM:300321]. FG syndrome (FGS) is an X-linked disorder characterized by mental retardation, relative macrocephaly, hypotonia and constipation.
Defects in FLNA are the cause of terminal osseous dysplasia (TOD) [MIM:300244]. A rare X-linked dominant male-lethal disease characterized by skeletal dysplasia of the limbs, pigmentary defects of the skin and recurrent digital fibroma during infancy. A significant phenotypic variability is observed in affected females.
Defects in FLNA are the cause of cardiac valvular dysplasia X-linked (CVDX) [MIM:314400]. A rare X-linked heart disease characterized by mitral and/or aortic valve regurgitation. The histologic features include fragmentation of collagenous bundles within the valve fibrosa and accumulation of proteoglycans, which produces excessive valve tissue leading to billowing of the valve leaflets.
Belongs to the filamin family.
Contains 1 actin-binding domain.
Contains 2 CH (calponin-homology) domains.
Contains 24 filamin repeats.
Comprised of a NH2-terminal actin-binding domain, 24 internally homologous repeats and two hinge regions. Repeat 24 and the second hinge domain are important for dimer formation.
Phosphorylated upon DNA damage, probably by ATM or ATR (By similarity). Phosphorylation extent changes in response to cell activation.
The N-terminus is blocked.
Cytoplasm > cell cortex. Cytoplasm > cytoskeleton.
Target information above from: UniProt accessionP21333
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Flow Cytometry-Filamin A antibody [EP2405Y] - Carboxyterminal end(ab76289)
![Flow Cytometry-Filamin A antibody [EP2405Y] - Carboxyterminal end(ab76289)](/ps/datasheet/images/76/ab76289/Filamin-A-Primary-antibodies-ab76289-3.jpg)
Overlay histogram showing A431 cells stained with ab76289 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Triton X-100 for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab76289 , 1/100 dilutio) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in A431 cells fixed with 4% paraformaldehyde/permeabilized in 0.1% PBS-Triton X-100 used under the same conditions.
Western blot - Filamin A antibody [EP2405Y] - Carboxyterminal end (ab76289)
![Western blot - Filamin A antibody [EP2405Y] - Carboxyterminal end (ab76289)](/ps/datasheet/Images/76/ab76289/ab76289_1.jpg)
All lanes : Anti-Filamin A antibody [EP2405Y] - Carboxyterminal end (ab76289) at 1/500000 dilution
Lane 1 : COS-1 cell lysate
Lane 2 : Hela cell lysate
Lane 3 : 3T3 cell lysate
Lane 4 : C6 cell lysate
Lysates/proteins at 10 µg per lane.
Secondary
HRP labelled goat anti-rabbit at 1/1000 dilution
Predicted band size : 281 kDa
Observed band size : 281 kDa
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Filamin A antibody [EP2405Y] - Carboxyterminal end (ab76289)
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Filamin A antibody [EP2405Y] - Carboxyterminal end (ab76289)](/ps/datasheet/Images/76/ab76289/ab76289_2.jpg)
Immunohistochemical analysis of paraffin-embedded human uterus using ab76289 at a 1/100 dilution.
Immunocytochemistry/ Immunofluorescence - Filamin A antibody [EP2405Y] - Carboxyterminal end (ab76289)
![Immunocytochemistry/ Immunofluorescence - Filamin A antibody [EP2405Y] - Carboxyterminal end (ab76289)](/ps/datasheet/Images/76/ab76289/ab76289_3.jpg)
Immunofluorescent staining of HeLa cells using ab76289 at a 1/100 dilution.
This product has been referenced in:
See 1 publication for this product
Publishing research using ab76289? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Flow Cytometry-Filamin A antibody [EP2405Y] - Carboxyterminal end(ab76289)](/ps/datasheet/images/76/ab76289/Filamin-A-Primary-antibodies-ab76289-3.jpg)
Overlay histogram showing A431 cells stained with ab76289 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Triton X-100 for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab76289 , 1/100 dilutio) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (
![Western blot - Filamin A antibody [EP2405Y] - Carboxyterminal end (ab76289)](/ps/datasheet/Images/76/ab76289/ab76289_1.jpg)
All lanes : Anti-Filamin A antibody [EP2405Y] - Carboxyterminal end (ab76289) at 1/500000 dilution
Lane 1 : COS-1 cell lysate
Lane 2 : Hela cell lysate
Lane 3 : 3T3 cell lysate
Lane 4 : C6 cell lysate
Lysates/proteins at 10 µg per lane.
Secondary
HRP labelled goat anti-rabbit at 1/1000 dilution
Predicted band size : 281 kDa
Observed band size : 281 kDa
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Filamin A antibody [EP2405Y] - Carboxyterminal end (ab76289)](/ps/datasheet/Images/76/ab76289/ab76289_2.jpg)
Immunohistochemical analysis of paraffin-embedded human uterus using ab76289 at a 1/100 dilution.
![Immunocytochemistry/ Immunofluorescence - Filamin A antibody [EP2405Y] - Carboxyterminal end (ab76289)](/ps/datasheet/Images/76/ab76289/ab76289_3.jpg)
Immunofluorescent staining of HeLa cells using ab76289 at a 1/100 dilution.
2
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
